Will Waterfield, Principal Consultant, Sayan Paria, Associate Consultant, and Hisham Nachabe, Analyst, will attend Microbiome Connect: Gut Therapeutics, a conference that provides a forum for professionals who are actively seeking to “overcome challenges in R&D and manufacturing within the gut microbiome field,” on November 17 – 18 at Courtyard by Marriott, Boston Downtown Boutique Hotel.... Read More
Marco Daoura, Principal (Strategic Consulting, Medical Devices, Digital Health and HealthIT), will attend HLTH 2021 on October 17 – 20 at the Boston Convention & Exhibition Center. His attendance at the event, which is “the preeminent event designed for the health industry, bringing together senior leaders to solve healthcare’s most pressing problems and realize the... Read More
LBG is pleased to announce that Dr. Bob Huebner, Principal Consultant, will participate in a panel at BioKansas’ Community Forum entitled “Accelerating Biologics: The Market Landscape and Engineering Advancements” on October 21. He was invited to speak about the current biologics landscape and the future direction of the industry before the panel begins. Dr. Huebner... Read More
LBG would like to congratulate Dr. Josh Speidel, who was invited to participate in the BioProcess Insider State of the Industry webcast on September 15! Chosen for his expertise, Dr. Speidel joined the BioProcess Insider editorial team and two fellow panelists to discuss the pharma industry’s impact on the biomanufacturing space as well as trends... Read More
“Each year BioProcess International publishes over 150 technical and scientific articles focusing on the latest science, technologies, and techniques supporting biopharmaceutical research, development, and manufacturing.” BioProcess International, Your Choices for BPI’s Best Articles, 2021 This year’s rankings were constructed based on views, engagement, and download rates; and led to the selection of the four most popular articles... Read More
Sponsored by Center for Entrepreneurship, in partnership with the College of Arts and Sciences Department of Biology, Corporate Engagement Office, and TechGROWTH Ohio. November 18, 2020 Robert Huebner, a Principal Consultant with Latham BioPharm Group, participated in a panel discussion hosted by Ohio University this week. The topic was Pandemic Preparedness and Response. Dr. Huebner... Read More
Sponsored by Independence Blue Cross & B. PHL Innovation Fest Presented by Venture Café Philadelphia LBG’s Gervan Williams joined a diverse panel of experts to discuss emerging opportunities for innovators, investors, and support organizations to create a better future for all through innovation in life science. The panelists shared how they incorporate purpose into their daily... Read More
Timothy Alcorn co-authored a paper published by Lab on a Chip titled, “Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19†”. Dr. Alcorn is the Director of Medical Devices and Diagnostics for Latham BioPharm Group and was consulted for his expertise in this area. This paper was also... Read More
“There’s (a) fine balance between getting the test out there fast and making sure the test is accurate,” says Dr. Tim Alcorn, Director of Medical Devices and Diagnostics at Latham BioPharm Group. Dr. Alcorn, an expert in his field, was interviewed and quoted in a recent article about testing for the Coronavirus published by U.S.... Read More
LBG is thrilled to announce the addition of Dr. Robert Casillas, Dr. Thijs Beuming and Dr. Darrel J. Rezac to our Team—each of whom brings unique expertise that widens the portfolio of services we are able to offer to our clients. Robert P. Casillas, Ph.D., Fellow ATS Director, specializing in Nonclinical Consulting Thijs Beuming, Ph.D.... Read More
Interested in our services? Contact us today to setup an appointment.